Barclays raised the firm’s price target on Sapiens (SPNS) to $31 from $28 and keeps an Underweight rating on the shares post the Q1 report. Sapiens is continuing with its strategy-optimizing product offerings and leveraging its existing customer base, this quarter making two acquisitions, the analyst tells investors in a research note. The firm thinks it is too early to become constructive on the shares.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SPNS:
- Sapiens International Reports Steady Q1 2025 Growth
- Sapiens International’s Earnings Call: Strategic Growth Amid Challenges
- Sapiens Announces Q1 2025 Financial Results and Strategic Acquisitions
- Sapiens reports Q1 EPS 37c, consensus 35c
- Sapiens raises FY25 revenue view to $574M-$578M from $553M-$558M
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue